Pulmonary Blastoma: A Rare Primary Lung Malignancy

Pulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manne...

Full description

Bibliographic Details
Main Authors: Mahmoud S. Alahwal, Iqbal H. Maniyar, Faiza Saleem, Mariam Alshiekh
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2012/471613
id doaj-28b44046107b4843a821311f1277b436
record_format Article
spelling doaj-28b44046107b4843a821311f1277b4362020-11-24T23:28:38ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352012-01-01201210.1155/2012/471613471613Pulmonary Blastoma: A Rare Primary Lung MalignancyMahmoud S. Alahwal0Iqbal H. Maniyar1Faiza Saleem2Mariam Alshiekh3Medical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaMedical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaMedical Oncology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaFaculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi ArabiaPulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manner from histopathological features. Classic pulmonary blastoma is composed of a mixture of immature epithelial and mesenchymal tissue resembling fetal lung tissue. Surgery is the mainstay of treatment. The prognosis of this rare malignancy is poor and the overall 5-year survival is around 15%. Our patient presented with respiratory symptoms and was found to have right-sided chest wall mass. The patient underwent complete surgical excision followed by 6 cycles of platinum-based chemotherapy. The patient showed good subjective and objective response with no evidence of disease recurrence. We report this rare malignancy with a review of literature, and the potential to use adjuvant chemotherapy in the management of this condition.http://dx.doi.org/10.1155/2012/471613
collection DOAJ
language English
format Article
sources DOAJ
author Mahmoud S. Alahwal
Iqbal H. Maniyar
Faiza Saleem
Mariam Alshiekh
spellingShingle Mahmoud S. Alahwal
Iqbal H. Maniyar
Faiza Saleem
Mariam Alshiekh
Pulmonary Blastoma: A Rare Primary Lung Malignancy
Case Reports in Medicine
author_facet Mahmoud S. Alahwal
Iqbal H. Maniyar
Faiza Saleem
Mariam Alshiekh
author_sort Mahmoud S. Alahwal
title Pulmonary Blastoma: A Rare Primary Lung Malignancy
title_short Pulmonary Blastoma: A Rare Primary Lung Malignancy
title_full Pulmonary Blastoma: A Rare Primary Lung Malignancy
title_fullStr Pulmonary Blastoma: A Rare Primary Lung Malignancy
title_full_unstemmed Pulmonary Blastoma: A Rare Primary Lung Malignancy
title_sort pulmonary blastoma: a rare primary lung malignancy
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2012-01-01
description Pulmonary blastoma, a rare primary lung malignancy, is considered to be distinct from other lung tumors based on pathological features, clinical course, and prognosis. More than one hundred cases have been reported in literature highlighting an interesting fact about their distinctive biologic manner from histopathological features. Classic pulmonary blastoma is composed of a mixture of immature epithelial and mesenchymal tissue resembling fetal lung tissue. Surgery is the mainstay of treatment. The prognosis of this rare malignancy is poor and the overall 5-year survival is around 15%. Our patient presented with respiratory symptoms and was found to have right-sided chest wall mass. The patient underwent complete surgical excision followed by 6 cycles of platinum-based chemotherapy. The patient showed good subjective and objective response with no evidence of disease recurrence. We report this rare malignancy with a review of literature, and the potential to use adjuvant chemotherapy in the management of this condition.
url http://dx.doi.org/10.1155/2012/471613
work_keys_str_mv AT mahmoudsalahwal pulmonaryblastomaarareprimarylungmalignancy
AT iqbalhmaniyar pulmonaryblastomaarareprimarylungmalignancy
AT faizasaleem pulmonaryblastomaarareprimarylungmalignancy
AT mariamalshiekh pulmonaryblastomaarareprimarylungmalignancy
_version_ 1725548700140306432